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Central and peripheral pools of biogenic monoamine serotonin (5-hydroxytryptamine
[5HT]) exert opposite effects on the body weight regulation: increase in brain 5HT activity
is expected to decrease body weight, whereas increase in peripheral 5HT activity will
increase body weight and adiposity. In a genetic model of rats with constitutionally high-
or low-5HT homeostasis (hyperserotonergic/hyposerotonergic rats), we have studied
how individual differences in endogenous 5HT tone modulate net energy balance of
the organism. The high-5HT and low-5HT sublines of the model were developed by
selective breeding toward extreme platelet activities of 5HT transporter, a key molecule
determining 5HT bioavailability/activity. In animals from high-5HT and low-5HT sublines,
we assessed physiological characteristics associated with body weight homeostasis
and expression profile of a large scale of body weight–regulating genes in hypothalamus,
a major brain region controlling energy balance. Results showed that under standard
chow diet animals from the high-5HT subline, as compared to low-5HT animals, have
lifelong increased body weight (by 12%), higher absolute daily food intake (by 9%),
and different pattern of fat distribution (larger amount of white adipose tissue and
lower amount of brown adipose tissue). A large number of body weight–regulating
hypothalamic genes were analyzed for their mRNA expression: 24 genes by reverse
transcription–quantitative polymerase chain reaction (n = 9–10 rats/subline) including
neuropeptides and their receptors, growth factors, transcriptional factors, and receptors
for peripheral signals, and a total of 84 genes of various classes by polymerase chain
reaction array (pools of six rats/subline). Only few genes showed significant differences in
mRNA expression levels between 5HT sublines (e.g. neuropeptide Y receptor, fibroblast
growth factor 10), but high-5HT animals displayed a clear trend to upregulation of
mRNAs for a number of orexigenic signaling peptides, their receptors, and other
molecules with orexigenic activity. Receptors for peripheral signals (leptin, insulin) and
molecules in their downstream signaling were not altered, indicating no changes in
central insulin/leptin resistance. At the protein level, there were no differences in the
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content of hypothalamic leptin receptor between 5HT sublines, but significant sex and
age effects were observed. Results show that higher constitutive/individual 5HT tone
favors higher body weight and adiposity probably due to concurrent upregulation of
several hypothalamic orexigenic pathways.
Keywords: serotonin transporter, rat model, obesity, hypothalamus, body weight homeostasis, energy balance
INTRODUCTION
Serotonin (5-hydroxytryptamine [5HT]) in mammalian
organism exists in two functionally independent compartments,
central and peripheral, which are separated with, for the
amine impermeable, blood–brain barrier. In the brain, 5HT
is synthesized in neurons of the brainstem raphe nuclei and
released into synapse to act as a neuromodulator of many brain
circuits. In the periphery, it is produced mostly by intestinal
mucosa and released into circulation. Blood platelets transport
5HT throughout and release it on various stimuli to activate 5HT
receptors on cells in different peripheral organs mediating thus
their functions (Berger et al., 2009). In both compartments, 5HT
signaling is ceased by the rapid action of membrane serotonin
transporter (5HTT), which (re)uptakes released 5HT back to
neurons or into blood platelets. Pharmacological inhibition of
5HTT experimentally or with therapeutic purposes elevates
extracellular 5HT level in parallel in both compartments, thus
increasing serotonin action in the whole body.
Dysregulation of 5HT signaling is implicated in many
pathological conditions, including obesity and other metabolic
disorders. The role of the brain 5HT system in the regulation
of body weight has been known for a long time (Curzon, 1990),
whereas importance of peripheral 5HT in energy homeostasis
emerged just recently (Donovan and Tecott, 2013; Namkung
et al., 2015; Spohn and Mawe, 2017; Yabut et al., 2019). Soon
it became evident that brain and peripheral 5HT systems likely
exert opposite effects on metabolic homeostasis (Oh et al., 2016;
Wyler et al., 2017).
In the brain, nucleus arcuatus of the hypothalamus is a key
structure regulating the body’s metabolic processes. It senses
and integrates peripheral signals and adjusts accordingly the
expression of orexigenic and anorexigenic peptides. Two major
neuronal populations are involved in the appetite regulation:
neuropeptide Y (Npy) and agouti-related peptide (Agrp)
stimulate feeding and decrease energy expenditure, whereas
proopiomelanocortin (Pomc) and cocaine- and amphetamine-
related transcript (Cart) have the opposite actions. Both
circuits project to downstream hypothalamic nuclei where
second-order neuropeptide neurons are located that further
control energy homeostasis by releasing regulatory factors
such as hypocretin (Hcrt/orexin), melanin-concentrating
hormone (Mch), and brain-derived neurotrophic factor (Bdnf)
(Timper and Brüning, 2017).
Serotonergic neurons are involved in the control of food
intake in a way that increased 5HT signaling suppresses feeding
and tend to decrease body weight gain (Curzon, 1990; Lam
et al., 2010; Voigt and Fink, 2015). In addition, it increases
energy expenditure by enhancing sympathetic outflows to brown
adipose tissue (Morrison et al., 2014). Hence, pharmacological
elevation of brain 5HT activity has been suggested as a possible
antiobesity treatment (Burke and Heisler, 2015). Anorectic 5HT
action is exerted through its binding to 5HT1B receptor on
hypothalamic Npy/Agrp neurons and to 5HT2C receptors on
Pomc/Cart neurons (Heisler et al., 2006). Increased hypothalamic
5HT signaling during development has been suggested to play
an important role in a widely acknowledged hypothalamic
programming of body mass (Martin-Gronert et al., 2016).
In the periphery, 5HT controls energy homeostasis by acting
on various metabolic organs as a gut-derived hormone or
autocrine/paracrine signaling molecule (Spohn and Mawe, 2017;
Wyler et al., 2017; Yabut et al., 2019). It stimulates adipogenesis
(Kinoshita et al., 2010), reduces lipolysis (Sumara et al., 2012),
promotes insulin secretion (Paulmann et al., 2009), and inhibits
glucose production (Sumara et al., 2012). 5HT also blunts
thermogenic activity of brown adipose tissue (Crane et al.,
2015; Oh et al., 2015). Pharmacologic inhibition or genetic
deletion of a rate-limiting enzyme in peripheral 5HT synthesis
protects mice from high-fat diet–induced obesity and insulin
resistance (Sumara et al., 2012). Therefore, decreasing peripheral
5HT signaling was suggested as a new strategy for antiobesity
treatment (Watanabe et al., 2011; Crane et al., 2015).
The existence of a bimodal control system where central
and peripheral increase in 5HT bioavailability exerts the
opposite effects on body weight regulation prompted us to
investigate how interindividual differences in endogenous 5HT
tone will affect net energy balance of the organism. For this
purpose, we have used Wistar–Zagreb 5HT (WZ-5HT) rats
with constitutionally altered 5HT homeostasis. Two sublines of
the model, high-5HT and low-5HT subline, were developed by
selective breeding of rats toward naturally occurring extremes
of platelet 5HT parameters: platelet 5HT level and maximal
velocity of platelet 5HT transporter (Cicin-Sain et al., 1995, 2005;
Jernej et al., 1999; Cicin-Sain and Jernej, 2010). Genetic selection
of animals for peripheral 5HT resulted also in differences in
central 5HT homeostasis between 5HT sublines, as concluded
from neurochemical, pharmacological, behavioral, and other
functional studies (Romero et al., 1998; Hranilovic et al.,
2005; Cicin-Sain and Jernej, 2010; Bordukalo-Niksic et al.,
2010). In particular, animals from the high-5HT subline, in
comparison to the low 5HT subline, showed higher 5HT turnover
in several brain regions, higher hippocampal 5HT recovery
in vivo, and higher KCl- and citalopram-induced elevation in
extracellular 5HT as measured by microdialysis, as well as higher
brain 3H-citalopram binding as measured by autoradiography.
All obtained results indicate different brain/peripheral 5HT
system functioning between 5HT sublines. Generally, animals
from the high-5HT subline are considered constitutionally
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hyperserotonergic in comparison to animals the from the low-
5HT subline. One of the consequences of described genetic
selection was an overweight phenotype of high-5HT animals,
associated with bone loss, adiposity, and peripheral insulin
resistance (Erjavec et al., 2016). In the present study, we
investigated phenotypic/functional differences between animals
from 5HT sublines and searched how endogenous, lifelong
alteration in 5HT signaling shapes hypothalamic expression
status of key body weight–regulating molecules.
MATERIALS AND METHODS
Animals
Studies were performed on two sublines of WZ-5HT rats
developed by directed selective breeding toward the extreme
values of platelet serotonin level (PSL) and velocity of platelet
serotonin uptake (PSU) at the Rud¯er Boškovic´ Institute (Zagreb,
Croatia). The generation of 5HT sublines has been described
previously (Cicin-Sain et al., 1995, 2005; Cicin-Sain and Jernej,
2010). Just in brief, males and females with the highest and the
lowest values of platelet 5HT parameters were chosen from a
large base population of Wistar rats and mated to generate high-
5HT and low-5HT subline, respectively. Determinations of PSL
and PSU were performed in offspring of each generation at the
age of 5–6 weeks, and animals displaying the extreme values
were selected as parents for the next generation. Divergence
of mean PSL values stabilized after 5 to 6 generations at
approximately 70% (low-5HT subline) and 150% (high-5HT
subline) of the mean value of the starting population. In this
study, the age of animals varied from 24 h to 9 months
(indicated in figures), and both sexes were used. Animals were
housed three per cage under controlled conditions (temperature
22◦C ± 2◦C; humidity 55% ± 10%; 12-h light–dark cycle)
with standard rat chow (4RF21, 3.9 kcal/g, 6.55% kcal from fat;
Mucedola, Settimo Milanese, Italy) and water ad libitum. All
experiments were approved by the institutional and national
(Ministry of Agriculture, Republic of Croatia) ethical committees
and conducted in accordance with the ILAR Guide for the Care
and Use of Laboratory Animals and Croatian animal protection
law (NN 135/06 and 37/13).
Measurements of Body Weight, Food,
and Water Intake
Body weight of pups was measured 24 h after delivery.
Average pup weight was calculated for four litters/subline with
comparable number of pups (10–13 pups/litter, 44 pups/subline)
and the same ratio of male-to-female offspring, as determined on
postnatal day 7.
Milk intake in pups was determined by weight–suckle–weight
method (Hernandez et al., 2012). Testing was performed on five
occasions (every other day from postnatal days 9–17) in litters
with equal number of newborns delivered at the same time of day.
At 8 AM, pups were removed from mothers for 4 h. At 12 AM, all
pups were weighed, returned to their mothers to nurse for 45 min,
and weighed again to estimate milk intake per litter. Milk intake
per pup was obtained by dividing total milk intake by the number
of pups in each litter.
Food consumption in adults was measured in males aging
5.5 months. At 9 AM, rats were weighted, placed individually
in cages, and presented with preweight amount of food. After
24 h, remaining food was weighed, and the amount of food
consumed was obtained by subtracting the uneaten food. Daily
water consumption was quantified (at 9 AM) using rat volumetric
drinking tubes with Lixit valve (Med Associates, Inc., Fairfax,
VT, United States). A week prior to experiment, rats were
habituated to drinking tubes, and during experiments, they were
caged individually. The body length of isoflurane-anesthetized
animals was measured from their nose tip to the tail base using
millimeter paper.
Tissue Collection
Animals were sacrificed by decapitation; brains were rapidly
removed from the skull and placed with the dorsal side facing
the chilled plate for dissection. Using curved forceps and
the rat brain stereotaxic atlas (De Groot, 1959) as a guide,
a hypothalamus was carefully removed. The curved part of
the forceps was pushed down around the hypothalamus, and
hypothalamus was gently pinched out (while pushing down
with forceps). It was weighted and either immediately frozen
in liquid nitrogen for array expression analyses and enzyme-
linked immunosorbent assay (ELISA) determination, or placed
in RNAlater solution as recommended by the manufacturer
(Qiagen, Venlo, Netherlands) for reverse transcription–
quantitative polymerase chain reaction (RT-qPCR) analyses. All
samples were stored at −80◦C until further analyses. Gonadal
white adipose tissue (WAT), brown adipose tissue (BAT), liver,
heart, and spleen were carefully dissected and weighed.
Biochemical Measurements
Platelet serotonin level was determined spectrophotometrically,
and velocity of PSU was measured radiochemically in the same
blood sample obtained from rat jugular vein under isoflurane
anesthesia (SomnoSuite anesthesia system; Kent Scientific,
Torrington, CT, United States) as described previously (Jernej
et al., 1999; Cicin-Sain et al., 2005).
Measurements of selected proteins’ levels were performed by
commercial ELISAs. Tissue was homogenized in 1:10 wt/vol
tissue protein extraction reagent (T-PER; Thermo Fisher
Scientific, Waltham, MA, United States) with protease inhibitor
(Halt Protease Inhibitor Cocktail; Thermo Fisher Scientific)
added. The resulting lysates were centrifuged (10,000 g, 10 min),
and the supernatants were assayed for leptin receptor (Lepr),
Bdnf, ciliary neurotrophic factor (Cntf), fibroblast growth factor
10 (Fgf10), and 5HTT levels according to manufacturers’
(Elabscience, Wuhan, China) protocols. Assay sensitivities were
18.75 pg/mL for Lepr and Bdnf, 9.38 pg/mL for Fgf10, 7.50 pg/mL
for Cntf, and 0.10 ng/mL for 5HTT. Total protein content in
homogenates was determined by the Bradford method.
Determination of hypothalamic levels of 5HT and its
metabolite 5-hydroxyindoleacetic acid (5HIAA) was performed
using high-performance liquid chromatography (HPLC) with
electrochemical detection. Tissue samples were homogenized in
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10 volumes (vt/wol) of 0.1 M HClO4 containing 0.2 mM EDTA
and 0.4 mM Na2S2O5 and centrifuged at 14,000 g for 15 min
at +4◦C. Supernatants were filtered, and 20 µL aliquots were
injected into the C8 reverse-phase HPLC column (StableBond
SB-C8, 3.5 µm, 4.6 × 75 mm; Agilent Technologies, Santa
Clara, CA, United States) and protected with guard column
(LiChrospher 100 RP-18.5 µm, 4× 4 mm; Agilent Technologies).
The mobile phase contained 0.1 M Na2HPO4, 0.05 M citric acid,
10% methanol, 0.1 mM EDTA, and 1 mM KCl. The elution was
performed at a flow rate of 0.5 mL/min at a pressure of 60 bars.
An electrochemical detector (1049A; Hewlett-Packard, Palo Alto,
CA, United States) with a glassy carbon electrode was used at
+0.60 V versus reference electrode. Quantitative determinations
were made by comparison with appropriate external standards
using an integrator. The turnover of amine was calculated as the
metabolite-to-neurotransmitter ratio.
Gene Expression Analysis
Total RNA from approximately 30 mg of hypothalamus
was isolated with RNeasy Mini Kit (Qiagen) according to
manufacturer’s protocol including on-column DNA digestion
step. Concentration and purity of isolated RNAs were assessed by
spectrophotometry (NanoPhotometer; Implen, Westlake Village,
CA, United States). A260/A280 ratio was between 2.16 and 2.34.
Aliquots of RNA were run on 1% agarose gel electrophoresis
to verify integrity; all samples showed sharp 28S and 18S bands
in approximately 2:1 ratio. RNA samples were stored at −80◦C
until further processing. Relative levels of specific mRNAs were
determined using the RT-qPCR based on SYBR Green detection
chemistry. cDNA was synthesized from 1,200 ng of each RNA
in a final volume of 20 µL using the High-Capacity RNA
to cDNA Synthesis Kit (Applied Biosystems, Foster City, CA,
United States) according to manufacturer’s protocol. Control
reactions lacking reverse transcriptase (no-RT) were prepared
in order to test genomic DNA contamination. For each tissue,
cDNA was synthesized also from the pool of all RNA samples
in order to be used for preparing standard curves. cDNAs were
diluted to concentration of 6 ng/µL and stored in small aliquots
at −20◦C. Sequences of the primers used in qPCR are listed in
Supplementary Table 1. Quantitative PCR assays were prepared
using the Fast SYBR Green Master Mix, in a total volume of
10 µL, and were run on a StepOnePlus Real-Time PCR System
(both from Applied Biosystems) according to manufacturer’s
protocol. Each qPCR plate included a 5-point standard curve
with twofold serial dilution, and all reactions were performed
in duplicates. Relative expression levels were determined using
a relative standard curve method (Larionov et al., 2005) and were
normalized to the mean of two reference genes, glyceraldehyde-
3-phosphate dehydrogenase (Gapdh) and actin beta (Actb).
Rat Obesity RT2 Profiler PCR Array (Qiagen) was used
for measuring expression levels of hypothalamic body weight–
regulating molecules in RNA pools obtained from six animals
per subline. First-strand cDNA was synthesized from 500 ng
of each RNA pool using the RT2 First Strand Kit (Qiagen)
according to the manufacturer’s instructions. PCR Array assays
were prepared using the RT2 qPCR SYBR Green/ROX Master
Mix (Qiagen) as recommended. Reactions were run on a 7300
Real Time PCR System (Applied Biosystems) employing standard
cycling conditions (95◦C for 10 min; 40 cycles of 95◦C for 15 s
and 60◦C for 1 min), followed by dissociation curve analysis.
Positive PCR control for interassay comparison as well as controls
for genomic DNA contamination and reverse transcription all
passed quality control. Genes with quantification cycle (Cq)
greater than 30 are listed in Table 1 (Complete list of the
analyzed genes may be found at1). The expression of each gene
of interest was normalized to mean of five housekeeping genes
(Rplp1, Hprt1, Rpl13a, Ldha, and Actb). The fold change in
relative expression level in high-5HT as compared to low-5HT
subline was calculated using the comparative Cq (11Cq) method
(Livak and Schmittgen, 2001).
Statistical Analysis
Statistical analyses were performed using GraphPad Prism v.02.
Normality of data distribution was tested by D’Agostino–Pearson
omnibus test, homogeneity of variances by Bartlett test, and
presence of outliers by Grubbs test. Means between two groups
were compared with two-tailed unpaired Student t-test (with
Welch correction if variances were significantly different) or
Mann–Whitney U test, as appropriate. Food intake was analyzed
by repeated-measures analysis of variance followed by Fisher
least significant difference test. Relationship between biochemical
measures was evaluated by Pearson correlation coefficient.
Results are presented as individual values and/or group means
with standard deviation (SD) or standard error of the mean
(SEM). Differences were considered statistically significant if
p< 0.05.
RESULTS
Phenotypic characteristics of animals from 5HT sublines are
shown in Figure 1. Rats from high-5HT and low-5HT subline
displayed approximately twofold differences in PSL (high-
5HT/low-5HT, H/L = 1.96; Figure 1A) and velocities of PSU
(H/L = 1.78). Figure 1B shows dorsal view of a 9-month-old male
rat from high-5HT (left) and low-5HT (right) subline.
In comparison to low-5HT rats, high-5HT animals have a
higher body weight already at birth (12%, t = 4.68, p < 0.001;
Figure 1C), and similar differences between 5HT sublines were
present in adult animals (13%, t = 5.75, p < 0.001; Figure 1D).
There was a highly significant positive correlation between
blood 5HT level and body mass of animals from 5HT sublines
(r = 0.779, p < 0.001, n = 39; Supplementary Figure 1).
Correlation analyses performed separately for high-5HT and
low-5HT rats showed significant correlation only in the low-5HT
group (r = 0.533, p = 0.0226, n = 19; Supplementary Table 2).
To investigate whether alterations in energy intake are
responsible for body weight differences, we measured food
intake in pups and in adult animals from 5HT sublines. At
the age of 2 weeks, high-5HT pups have tendency to suckle
more milk than age-matched low-5HT pups (85%, t = 1.959,
1www.qiagen.com
2www.graphpad.com
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TABLE 1 | Expression level of hypothalamic body weight–regulating molecules in high-5HT and low-5HT sublines of WZ-5HT rats.
Symbol of gene Description Quantification cycle RER (H/L)
High 5HT Low 5HT
Adcyap1 Adenylate cyclase activating polypeptide 1 23.30 23.37 0.99
Adcyap1r1 Adenylate cyclase activating polypeptide 1 receptor 1 23.13 23.64 1.35
Adipor1 Adiponectin receptor 1 23.51 23.57 0.98
Adipor2 Adiponectin receptor 2 24.66 24.60 0.91
Adrb1 Adrenergic, beta- 1-, receptor 28.01 28.63 1.46
Agrp Agouti related protein homolog (mouse) 25.23 25.04 0.83
Apoa4 Apolipoprotein A-IV 29.26 28.44 0.54
Atrn Attractin 23.52 23.67 1.05
Bdnf Brain-derived neurotrophic factor 26.03 26.15 1.03
Brs3 Bombesin-like receptor 3 28.29 28.91 1.45
C3 Complement component 3 27.67 28.39 1.56
Calca Calcitonin-related polypeptide alpha 28.38 29.10 1.57
Calcr Calcitonin receptor 23.63 23.54 0.89
Cartpt CART prepropeptide 21.13 21.11 0.93
Cck Cholecystokinin 24.51 24.92 1.26
Cckar Cholecystokinin A receptor 27.46 27.79 1.18
Cnr1 Cannabinoid receptor 1 (brain) 24.16 24.33 1.07
Cntf Ciliary neurotrophic factor 25.82 25.99 1.07
Cntfr Ciliary neurotrophic factor receptor 23.64 24.18 1.38
Crh Corticotropin-releasing hormone 26.15 26.06 0.90
Crhr1 Corticotropin-releasing hormone receptor 1 27.04 27.36 1.19
Drd1a Dopamine receptor D1A 27.79 27.57 0.82
Drd2 Dopamine receptor D2 25.37 25.93 1.39
Gal Galanin prepropeptide 23.54 23.52 0.94
Galr1 Galanin receptor 1 25.56 25.35 0.82
Ghr Growth hormone receptor 26.48 26.97 1.33
Ghrl Ghrelin/obestatin prepropeptide 26.09 26.43 1.20
Ghsr Growth hormone secretagogue receptor 26.13 26.02 0.88
Glp1r Glucagon-like peptide 1 receptor 28.25 28.68 1.27
Grp Gastrin-releasing peptide 27.52 27.88 1.22
Grpr Gastrin-releasing peptide receptor 28.36 27.93 0.70
HcRt Hypocretin 22.23 22.70 1.32
Hcrtr1 Hypocretin (orexin) receptor 1 27.29 27.78 1.33
Hrh1 Histamine receptor H 1 26.93 27.08 1.05
Htr2c 5-Hydroxytryptamine (serotonin) receptor 2C 23.99 23.88 0.88
Il1a Interleukin 1 alpha 29.98 29.73 0.80
Il1r1 Interleukin 1 receptor, type I 28.14 28.44 1.16
Il6r Interleukin 6 receptor 27.88 28.01 1.04
Insr Insulin receptor 24.94 25.02 1.00
Lepr Leptin receptor 27.56 27.38 0.84
Mc3r Melanocortin 3 receptor 28.09 28.00 0.89
Mchr1 Melanin-concentrating hormone receptor 1 26.53 26.59 0.99
Nmb Neuromedin B 26.38 26.67 1.16
Nmbr Neuromedin B receptor 28.73 28.53 0.83
Nmu Neuromedin U 26.52 25.95 0.64
Npy Neuropeptide Y 24.76 24.46 1.07
Npy1r Neuropeptide Y receptor Y1 26.71 26.79 1.00
Nr3c1 Nuclear receptor subfamily 3, group C, member 1 24.08 24.22 1.04
Nts Neurotensin 24.37 24.58 1.09
Ntsr1 Neurotensin receptor 1 27.25 27.96 1.55
Oprk1 Opioid receptor, kappa 1 25.80 25.94 1.05
(Continued)
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TABLE 1 | Continued
Symbol of gene Description Quantification cycle RER (H/L)
High 5HT Low 5HT
Oprm1 Opioid receptor, mu 1 25.65 25.64 0.94
Pomc Proopiomelanocortin 22.10 22.05 0.92
Ppara Peroxisome proliferator–activated receptor alpha 27.09 27.06 0.92
Ppargc1a Peroxisome proliferator–activated receptor gamma, coactivator 1 alpha 25.19 25.52 1.20
Prlhr Prolactin-releasing hormone receptor 28.45 28.07 0.73
Ptpn1 Protein tyrosine phosphatase, non-receptor type 1 25.68 26.04 1.22
Ramp3 Receptor (G protein–coupled) activity modifying protein 3 28.32 28.87 1.39
Sigmar1 Sigma non-opioid intracellular receptor 1 23.36 23.66 1.17
Sort1 Sortilin 1 22.33 22.59 1.14
Sst Somatostatin 21.44 21.58 1.05
Sstr1 Somatostatin receptor 1 25.15 25.34 1.08
Thrb Thyroid hormone receptor beta 25.95 25.97 0.96
Trh Thyrotropin-releasing hormone 24.21 24.58 1.22
Trhr Thyrotropin-releasing hormone receptor 26.29 26.28 0.95
Expression levels were measured in RNA pools obtained from six animals per subline. The expression levels of genes of interest were normalized to mean of five
reference genes. Results are shown as relative expression ratio (RER) between high-5HT and low-5HT subline (H/L), and genes are sorted in alphabetical order.
Cq = quantification cycle.
p = 0.085; Figure 1E). In adults, rats from high-5HT subline
have significantly higher daily food intake when absolute amount
of consumed food is considered (by 9%, t = 2.662, p = 0.014;
Figures 1F,G), whereas their daily food intake adjusted for body
weight is significantly lower (by 7%, t = 3.291, p = 0.003;
Figures 1H,I), similarly as their weight-adjusted water intake (by
18%, t = 1.958, p = 0.068; Figure 1K).
Differences between 5HT sublines in absolute and relative
weight of several body organs are shown in Figures 1L,M,
respectively. Mass of gonadal WAT was significantly higher
(absolute mass by 26%, relative mass by 10%), and mass of
interscapular BAT was significantly lower in high-5HT rats
(absolute mass by 18%, relative mass by 27%) as compared to
low-5HT animals, showing different patterns of fat distribution
between 5HT sublines. Visceral and retroperitoneal WAT depots,
measured in the same way, were also increased in the high-
5HT subline (not shown). Animals from the high-5HT subline
had higher weight of heart and spleen (by 8% and 12%,
respectively; Figure 1L), as well as longer total body length (by
5%; Supplementary Figure 2).
Serotonergic parameters measured in hypothalami of 5HT
sublines are shown in Figure 2. Content of hypothalamic 5HT
and its metabolite 5HIAA between 5HT sublines did not differ,
and there was only a trend (22%, not significant) toward elevation
of 5HT turnover in high-5HT rats as compared to low-5HT
animals (Figure 2A). Expression analysis of hypothalamic 5HT-
related genes revealed significantly increased levels of mRNA for
5HTT (H/L = 1.41, t = 2.915, p = 0.009) in high-5HT animals,
whereas no significant differences between 5HT sublines were
present in the expression levels of genes coding for 5HT receptors
type 1B (H/L = 0.92) and 2C (H/L = 0.91) (Figure 2B). There
was a significant negative correlation between hypothalamic
expressions of these two 5HT receptor subtypes (r = -0.5295,
p = 0.0197, n = 19; Supplementary Figure 3), which was more
pronounced in low-5HT subline (Supplementary Table 3).
To investigate which molecules/pathways underlie observed
differences between 5HT sublines with regard to body weight
and fat distribution, we compared expression levels of various
body weight–regulating genes in their hypothalami. As can be
seen in Figure 3, no significant differences in mRNA expression
levels of hypothalamic neuropeptides were observed between
5HT sublines. There was a trend toward upregulation of Agrp
and Cart mRNAs in high-5HT rats (H/L = 1.29, t = 1.887,
p = 0.076, and H/L = 1.10, t = 1.856, p = 0.081, respectively).
Npy receptor mRNA level was significantly higher in high-5HT
rats as compared to low-5HT animals (H/L = 1.15, t = 3.737,
p = 0.001) (Figure 3A).
As to hypothalamic expression of transcriptional factors
involved in energy expenditure, in high-5HT animals Ppargc1b
mRNA was significantly increased (H/L = 1.10, t = 2.908,
p = 0.011), and Cebpa mRNA showed a tendency toward increase
(H/L = 1.12, t = 1.755, p = 0.090) in comparison to low-5HT
animals (Figure 3B).
There were no differences in mRNA expression of
receptors/transporters for peripheral signals: Lepr, insulin
receptor (Insr), adiponectin receptors (Adipor), glucose
transporter 3 (Glut3), and in mRNA expression of molecules in
their downstream signaling (insulin receptor substrates 1 and
2, signal transducer and activator of transcription 3) between
high-5HT and low-5HT animals (Figure 3D). On the other
hand, hypothalamic expression of Fgf seems to be upregulated
in high-5HT animals (Fgf10: H/L = 1.24, t = 2.970, p = 0.008;
Fgf2 and Fgf21: H/L = 1.08, ns) as compared to low-5HT animals
(Figure 3D). It should be noted that p-values were not corrected
for multiple testing, so it should be taken into account that some
of the results might be false positives due to type I error.
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FIGURE 1 | (A) Platelet serotonin level in rats from high-5HT and low-5HT sublines. Shown are values for males used in food intake study presented in F–I, but data
are representative of all experiments. Mean ± SD, n = 9 rats/subline. (B) Dorsal view of rats from high-5HT (left) and low-5HT (right) sublines. Males, 9 months of
age. (C) Body weight of pups from high-5HT and low-5HT litters measured 24 h after delivery. Individual values for pups from four litters per 5HT subline (10–13
pups/litter, equal number of males and females) are presented with indicated mean ± SD. N = 44 pups/subline. (D) Body weight of male animals from 5HT sublines
at the age of 5 months. Individual values, mean ± SD, n = 36 rats/subline. (E) Milk intake in pups from high-5HT and low-5HT litters (11 pups/litter) measured by
weight–suckle–weight method. Average of five measurements from 9 to 17 postnatal days is given ±SD. (F–I) Daily food intake in animals from 5HT sublines
measured six times in the course of 2 weeks and expressed as total intake (g/animal/day, F,G) or relative to body weight of animals (g/kg body weight/day, H,I).
Mean ± SEM, n = 9 rats/subline. Histograms (G,I) show averaged six measurements ±SD. (J) Daily water intake in animals from 5HT sublines (mL/animal/day) and
(K) water intake adjusted for their body weight (mL/kg body weight/day). Mean values of four measurements in group of nine animals per subline ± SD are
presented. (L,M) Weight of gonadal white adipose tissue (WAT), interscapular brown adipose tissue (BAT), liver, heart, and spleen in 4.5-month-old males from
low-5HT and high 5HT subline expressed as absolute (g/animal, L) and relative (adjusted for body weight of animal; M) amount. Mean ± SD, n = 9 rats/subline.
FIGURE 2 | (A) Serotonin (5HT), its metabolite (5-hydroxyindoleacetic acid, 5HIAA), and their ratio (5HIAA/5HT) measured in whole hypothalamus of animals from
low-5HT and high-5HT sublines. Quantification was performed by HPLC-electrochemical method. Values are mean ± SEM, n = 6–7 rats/subline. (B) mRNA
expression levels of genes for serotonin transporter (5HTT) and serotonin receptors 5HT1B and 5HT2C, measured in hypothalamus of animals from 5HT sublines by
RT-qPCR analysis. Expression levels were normalized to mean of two reference genes (Actb and Gapdh). Results are shown as relative expression ratio between
animals from high-5HT and low-5HT subline. Mean ± SEM, n = 9–10 rats/subline.
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FIGURE 3 | Hypothalamic expression levels of weight-related molecules, neuropeptides, and their receptors (A), transcription factors (B), various peripheral
signaling molecules (C), and growth factors (D) in animals from 5HT sublines, measured by RT-qPCR analysis. Expression levels were normalized to mean of two
reference genes (Actb and Gapdh) and are shown as relative expression ratio between high-5HT and low-5HT subline. Mean ± SEM, n = 9–10 rats/subline.
Abbreviations: Agrp, agouti-related peptide; Adipor, adiponectin receptor; Bdnf, brain-derived neurotrophic factor; Cart, cocaine-and amphetamine-related
transcript; Cebpa, Cebpb Cebpd, CCAAT/enhancer binding protein alfa, beta, delta; Fgf, fibroblast growth factor; Glut3, glucose transporter 3; Hcrt, hypocretin;
Hcrtr, hypocretin receptor; Insr, insulin receptor; Irs, insulin receptor substrate; Lepr, leptin receptor; Mch, melanin-concentrating hormone; Npy, neuropeptide Y;
Npyr, neuropeptide Y receptor; Pomc, pro-opiomelanocortin; Ppargc1b, peroxisome proliferator-activated receptor gamma coactivator 1 beta; Stat3, signal
transducer and activator of transcription 3.
No differences in hypothalamic Lepr between 5HT sublines
were shown at the protein level (Figure 4). In all three groups
of animals that were analyzed (3- and 9-month-old males and 9-
month-old females), practically the same H/L ratio was obtained
ranging from 0.94 to 0.96 (Figures 4A–C). There was a tendency
of hypothalamic Lepr protein to decrease with age (by 7%,
t = 1.800, p = 0.081; Figure 4E). In addition, gender differences
were shown, with females having significantly higher Lepr protein
content than males, notwithstanding the 5HT subline (10%,
t = 2.491, p = 0.017; Figure 4F).
Observed differences between 5HT sublines in Fgf10 mRNA
expression were not confirmed at the protein level (Figure 5). In
both 5HT sublines, a significant influence of age was shown, with
values being almost twofold higher in older animals (Figure 5B).
Hypothalamic protein levels of two more growth factors, Bdnf
and Cntf, were also measured, but no differences between 5HT
sublines were shown either (not presented).
Limited molecular/biochemical differences observed between
5HT sublines motivated us to compare their hypothalamic
gene expression profile in a larger scale, using PCR Array
technology. Results of Rat Obesity RT2 Profiler PCR Array for
genes with quantification cycles higher than 30 are shown in
Table 1. Differences in hypothalamic expression levels of body
weight–regulating genes between 5HT sublines were in general
small, with H/L ratio ranging between 0.54 (apolipoprotein
A) and 1.57 (calcitonin-related polypeptide alfa). These data
were obtained with RNA pools of six animals per subline and
are considered preliminary. Still, there are several interesting
observations that will be discussed later that will direct our
further studies.
DISCUSSION
We report that, in our rat model, higher endogenous 5HT
tone is associated to increased body weight and adiposity of
the animal. The study investigates functional differences and
molecular/biochemical changes between constitutively obese
high-5HT rats and their constitutively lean counterparts,
low-5HT animals. Molecular perturbations in rodent obesity
have been studied mostly in relation to experimentally increased
caloric intake, while here we studied animals on normal chow
diet investigating the impact of endogenous 5HT tone on body
weight regulation.
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FIGURE 4 | Leptin receptor (Lepr) in hypothalamus of animals from low-5HT and high-5HT sublines, measured by ELISA. (A,B) Lepr levels in male rats aged 3 and
9 months. (C) Lepr levels in female rats aged 9 months. Data in panel (A–C) are presented as individual values with indicated mean ± SD, n = 9 rats/subline.
(D) Comparison of Lepr levels between 5HT sublines in different age groups (same data as A,B). There were no differences between age groups in either 5HT
subline. Histograms show mean ± SD, n = 9 rats/subline. (E) Lepr levels in relation to age: males of the same age from both sublines were pooled together, n = 18
rats per group. (F) Lepr levels in relation to gender: 9-month-old animals of the same sex from both sublines were pooled together, n = 18 rats per group. Data in E
and F are presented as box-and-whiskers (min–max) plot.
FIGURE 5 | Fibroblast growth factor 10 (Fgf10) levels in hypothalamus of animals from low-5HT and high-5HT sublines, aged 3 months (A) and 9 months (B),
measured by ELISA. Data are presented as individual values with indicated mean ± SD, n = 8–9 rats/subline. Significant age effect (C) was shown in both 5HT
sublines.
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Differences in body weight between 5HT sublines are
present already at birth, with low-5HT rats being lighter
and never reached up body weight of high-5HT animals
(Figures 1C,D). Adult high-5HT animals have a larger amount
of gonadal (Figure 1L) as well as visceral and retroperitoneal
(not shown) fat and also increased weight of some other
organs (e.g. heart, spleen; Figure 1L) in comparison to
low-5HT animals. They also have longer femurs (Erjavec
et al., 2016) and increased total body length (Supplementary
Figure 2). It could be concluded that differences in various
tissues/organs concurrently contribute to total body weight
differences between 5HT sublines. It is known that 5HT has
an important developmental role as a trophic/growth factor
(Gaspar et al., 2003) and that maternal 5HT activity impacts
fetal development (Côté et al., 2007; Muller et al., 2017). Hence,
increased birth weight of high-5HT pups may indicate that
maternal high 5HT tone stimulated their in utero growth.
Alternatively, decreased weight of low-5HT pups may be a
consequence of their own 5HT phenotype, similarly to transgenic
5HTT-overexpressing mice with reduced extracellular 5HT,
who are smaller and lighter than their wild-type littermates
(Pringle et al., 2008). Literature findings on the long-term
effects of pharmacologically induced rise in 5HT availability
during development on the body weight of animals are rather
inconsistent, showing either increased, decreased, or normal
body weight in later life (Grzeskowiak et al., 2012; Galindo
et al., 2015; De Long et al., 2015). Increased susceptibility
to adult obesity was related, among other possible factors, to
dysregulation of hypothalamic 5HT system during development
(Martin-Gronert et al., 2016).
In hypothalamus of high-5HT rats as compared to that of
low-5HT animals, we have shown increased 5HTT mRNA levels
(Figure 2), which, based on our previous biochemical/functional
findings (Romero et al., 1998; Cicin-Sain and Jernej, 2010),
we interpret as an enhanced 5HT synaptic activity (not as
an increased 5HT clearance from extracellular space). Relative
increase in 5HT turnover in high-5HT rats (H/L = 1.22; Figure 2),
although not significant here, is in line with previous results
showing elevated metabolic ratio in several brain regions of high-
5HT rats and may support their increased brain 5HT activity in
comparison to low-5HT animals.
Understanding how endogenous brain 5HTT activity
contributes to the body weight regulation is not clear. Similarly to
obese high-5HT rats, rodents with genetic deletion of 5HTT have
elevated extracellular 5HT levels and tissue 5HIAA/5HT ratios,
but findings regarding their obese phenotype are inconsistent
(Kim et al., 2005; Homberg et al., 2007; Murphy and Lesch,
2008; Homberg et al., 2010; Zha et al., 2017). Further, human
neuroimaging studies support both increase and decrease, as
well as no change in intrasynaptic 5HT level in obesity (Koskela
et al., 2008; Erritzoe et al., 2010; Hesse et al., 2016; Wu et al.,
2017; van Galen et al., 2018). Interestingly, while in morbid
obesity no changes in 5HTT binding were observed, moderately
obese subjects showed increased 5HTT-binding potential in
comparison to lean controls (Koskela et al., 2008). The findings
obtained in moderately obese individuals, being in line with
results obtained in our high-5HT rats, suggest that they might be
a good model for moderate, but not morbid, obesity. Further, in a
large group of healthy subjects with varying degrees of adiposity,
brain 5HT turnover was chronically elevated in proportion to
obesity (Lambert et al., 1999). Recently, an opposite correlation
between brain 5HTT bioavailability and body mass index in
obese and non-obese subjects was reported (Nam et al., 2018).
The complex relationship between 5HT and obesity is further
complicated by suggestion of inverse parabolic relationship
between 5HTT availability and 5HT level (van Galen et al., 2018).
Having in mind reports on the opposite effects of central and
peripheral 5HT pools on net energy balance (Namkung et al.,
2015; Oh et al., 2016; Wyler et al., 2017; Yabut et al., 2019), our
results indicate that in high-5HT animals with endogenously
increased endogenous 5HT tone obesogenic mechanisms of
peripheral 5HT prevail over anorexigenic action of central 5HT.
As to relation between brain 5HT activity and feeding,
pharmacological elevation of synaptic 5HT is repeatedly shown
to reduce food intake (Voigt and Fink, 2015), whereas genetic
manipulations bring about contrasting results. Thus, both 5HTT
knocking-out and 5HTT overexpression result in normal food
consumption together with increased and decreased body weight,
respectively, Murphy and Lesch (2008), Pringle et al. (2008). In
our sublines, the amount of food eaten by the animals correlated
with their body weights, so high-5HT rats consume significantly
higher absolute amount of food, whereas when adjusted for body
weight food intake of high-5HT animals is lower than in their
low-5HT counterparts (Figures 1F–I). This suggests important
differences in metabolic efficiency between high-5HT and low-
5HT animals. Adjusted water intake between 5HT sublines seems
to show similar relation as their food intake (Figure 1K). It
is known that in rodents food and water intakes are tightly
coordinated (Bachmanov et al., 2002), but how interactions
between eating and drinking are controlled by the brain is
not clear (Zimmerman et al., 2016). Observations on our 5HT
sublines indicate that regulation of appetite and thirst may be
under mutual coordinated control mediated by 5HT activity.
Observed differences in body weight and food/water intake
between 5HT sublines point to dysregulation of hypothalamic
mechanisms controlling these functions. Therefore, we have
analyzed the expression levels of hypothalamic neuropeptides
and their receptors in animals from 5HT sublines. Despite
described functional differences, there were no substantial
molecular changes in mRNA expression levels of body weight–
related hypothalamic peptides. Differences between 5HT
sublines, when existed, were small in amount and not quite
significant, but by summing up the overall effect, it seems that in
high-5HT animals orexigenic signaling peptides are, or tended
to be, upregulated in comparison to low-5HT animals (H/L:
Npy = 1.05; Npyr = 1.14, Agrp = 1.29; Hcrt = 1.06; Hcrtr = 1.17;
Mch = 1.09; Figure 3A), whereas anorexigenic peptides
show tendency in the opposite direction [H/L: Pomc = 0.94:
Bdnf = 0.97 (Figure 3) and also ApoA4 = 0.54; Crh = 0.90
(Table 1)]. Cart (H/L = 1.10) was suggested to be either
orexigenic or anorexigenic, based on the neural circuits that are
stimulated (Abdalla, 2017). It is possible that small changes in
neuropeptide mRNA expression levels will be more pronounced
if specific hypothalamic nuclei were analyzed.
Frontiers in Neuroscience | www.frontiersin.org 10 March 2020 | Volume 14 | Article 219
fnins-14-00219 March 23, 2020 Time: 20:7 # 11
Kesic´ et al. Serotonin and Body Weight Regulation
Coexistent increase in mRNA levels of several orexigenic
peptides in high-5HT rats suggests an overall increase in
the activity of orexigenic pathways and may underlay their
susceptibility to develop obesity. The upregulation of Npy
protein/mRNA level and/or its release was shown in obese
rodents (Kalra et al., 1999; Schaffhauser et al., 2002), as well
as in states associated with hyperphagia, such as fasting or
lactation (Kalra et al., 1999; Crowley et al., 2004). Increased Npy
receptor mRNA in high-5HT rats may indicate their increased
sensitivity to the effects of Npy, which is the most potent
natural orexigenic signal. Similarly, rats prone to diet-induced
obesity when fed normal chow have increased hypothalamic
Npy mRNA expression, as compared with diet-resistant rats
(Levin and Dunn-Meynell, 1997). Study of susceptibility of 5HT
sublines to develop obesity when fed high-fat diet is in course
in our laboratory, and preliminary results show their different
functional and molecular response to such metabolic challenge
(Kesic et al., 2019).
Alterations in Npy (and other orexigenic peptides) may also
contribute to lower basal thermogenic capacity of high-5HT rats
because activation of Npy/Agrp neurons was shown to decrease
BAT metabolic activity (Morrison et al., 2014; Waterson and
Horvath, 2015). Indeed, we have shown earlier that 5HT-high
rats display lower interscapular BAT temperature and lower
expression of uncoupling protein-1 (Kesic et al., 2018). Here,
smaller BAT mass (in both absolute terms and relative to
body weight) and altered pattern of fat distribution (increased
WAT and decreased BAT mass) in high-5HT animals were
demonstrated (Figures 1L,M).
Brain Npy-ergic circuits are probably best-characterized
pathways controlling energy homeostasis, but there are also
many other hypothalamic neurotransmitter/neuropeptide
circuits that complementarily regulate energy balance. By PCR
array experiments, we gained broad insight into pathways
that may be affected by constitutive alterations in 5HT
homeostasis. Array results need to be confirmed by individual
PCR experiments, but there are some observations that we
would like to note here. Thus, receptors for several anorectic
peptides that were suggested, or clinically tested, as an antiobesity
treatment (Cron et al., 2016; González et al., 2015; Vu et al.,
2015; Li et al., 2016) seem to be upregulated in high-5HT animals
(e.g. bombesin-like receptor 3: H/L = 1.45; neurotensin receptor
1: H/L = 1.55; Cntf receptor: H/L = 1.38; adenylate cyclase
activating polypeptide 1 receptor type 1: H/L = 1.35; Table 1).
This may suggest that individuals with higher 5HT tone would be
more sensitive to (therapeutic) administration of corresponding
neuropeptides/receptor agonists.
Further, PCR array results indicate that dysregulation of other
neurotransmitters involved in hypothalamic control of feeding
behavior and energy expenditure, specifically noradrenaline and
dopamine pathways, might contribute to obese phenotype of
high-5HT rats. Noradrenaline exerts strong orexigenic action
through the activation of excitatory β-adrenergic receptors
(Adrb) on Npy/Agrp neurons (Paeger et al., 2017), and Adrb1
seems to be upregulated in high-5HT (H/L = 1.46).
Hypothalamic activity depends on various peripheral signals
of energy balance among which leptin and insulin are the most
important. Both hormones act on arcuate nucleus via inhibition
of Npy/Agrp and activation of Pomc/Cart neurons, resulting in
reduced food intake and increased energy expenditure (Timper
and Brüning, 2017). In contrast to our expectation, there
were no differences between 5HT sublines in hypothalamic
mRNA expression of either Lepr or Insr or molecules in their
downstream signaling pathways (Figure 3C). It is not uncommon
that mRNA expression levels do not strictly correspond to
the protein level of the respective molecules (e.g. Kappeler
et al., 2004). Therefore, we analyzed Lepr protein levels in
hypothalami of 5HT sublines, but no differences were observed
either (Figure 4). To note, notwithstanding the 5HT subline,
significant sex and age differences were demonstrated in Lepr
protein levels in hypothalamus, with values being significantly
higher in younger than in older animals and in females than in
males (Figures 4E,F). Observed sex differences in Lepr protein
accord with higher sensitivity of females to the inhibitory effect
of leptin on food intake (Clegg et al., 2003) and highlight the
importance of evaluation of the effect of potential antiobesity
agents on body weight in both sexes. Absence of differences
in endogenous insulin/leptin signaling-related mRNA levels in
hypothalamus indicates that different adipose phenotype of 5HT
sublines is not associated with changes in central insulin/leptin
resistance. On the other hand, dysregulation in peripheral insulin
signaling was previously reported (Erjavec et al., 2016), with high-
5HT animals showing glucose intolerance and insulin resistance
in comparison to low-5HT subline.
Among molecules recently recognized as regulators of
metabolic functions, adipogenesis, and energy homeostasis,
several members of Fgfs (Fgf10, Fgf19, Fgf21) were also
suggested as candidates for novel antiobesity drugs (Ohta and
Itoh, 2014; Kyrou et al., 2017). In search for body weight–
regulating mechanisms affected by constitutional differences in
5HT tone, we analyzed mRNA expression levels of several Fgfs
in hypothalami of 5HT sublines and showed their upregulation
in high-5HT subline. However, significant increase in Fgf10
mRNA expression (H/L = 1.24; p = 0.008; Figure 3D) was
not paralleled with protein changes (Figure 5), indicating a
tight control of its level. The effect of aging on hypothalamic
Fgf10 protein level (Figure 5) is in line with its implication
in adult brain neurogenesis and, to our knowledge, is reported
for the first time.
CONCLUSION
In conclusion, by using selectively bred WZ-5HT rat sublines, we
have shown that constitutive 5HT tone is one of the endogenous
factors contributing to, or protecting from, becoming obese.
In particular, our results show that low endogenous 5HT tone
supports the maintenance of low body weight and low adiposity.
The important advantage of our rat model is that the difference
in platelet 5HTT activity between 5HT sublines is approximately
twofold, similarly to the degree of variation in the level of 5HTT
expression in healthy human population (Malison et al., 1998;
Murphy and Lesch, 2008). Hence, our model probably mimics
well-human physiological situation.
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